• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The need to define "who" rather than "if" for ECMO in COVID-19.

作者信息

Whebell Stephen, Zhang Joe, Lewis Rebecca, Berry Michael, Ledot Stephane, Retter Andrew, Camporota Luigi

机构信息

Intensive Care Unit, Townsville University Hospital, Townsville, QLD, Australia.

Department of Critical Care, King's College Hospital NHS Foundation Trust, London, UK.

出版信息

Intensive Care Med. 2022 Jul;48(7):979-980. doi: 10.1007/s00134-022-06732-y. Epub 2022 May 17.

DOI:10.1007/s00134-022-06732-y
PMID:35579687
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9112247/
Abstract
摘要

相似文献

1
The need to define "who" rather than "if" for ECMO in COVID-19.在新冠疫情中，确定体外膜肺氧合（ECMO）治疗的“适用人群”而非“是否适用”的必要性。
Intensive Care Med. 2022 Jul;48(7):979-980. doi: 10.1007/s00134-022-06732-y. Epub 2022 May 17.
2
Extracorporeal membrane oxygenation therapy in the COVID-19 pandemic.新冠疫情中的体外膜肺氧合治疗
Future Cardiol. 2020 Nov;16(6):543-546. doi: 10.2217/fca-2020-0040. Epub 2020 Apr 17.
3
ECMO combined with prone positioning strategies in COVID-19 respiratory distress syndrome.COVID-19 呼吸窘迫综合征中 ECMO 联合俯卧位治疗策略。
Perfusion. 2022 May;37(4):417-421. doi: 10.1177/0267659121995999. Epub 2021 Mar 5.
4
Seventy-seven days on veno-venous extracorporeal membrane oxygenation for severe acute respiratory distress syndrome from SARS-CoV-2.在 SARS-CoV-2 引起的严重急性呼吸窘迫综合征中进行静脉-静脉体外膜肺氧合 77 天。
Perfusion. 2023 Sep;38(6):1311-1314. doi: 10.1177/02676591221103545. Epub 2022 Jun 2.
5
Extracorporeal membrane oxygenation support for SARS-CoV-2: a multi-centered, prospective, observational study in critically ill 92 patients in Saudi Arabia.体外膜肺氧合支持治疗严重急性呼吸综合征冠状病毒 2 型感染：沙特阿拉伯 92 例危重症患者的多中心、前瞻性、观察性研究。
Eur J Med Res. 2021 Dec 9;26(1):141. doi: 10.1186/s40001-021-00618-3.
6
An Extracorporeal Membrane Oxygenation First Strategy in COVID-19 Acute Respiratory Distress Syndrome.COVID-19 急性呼吸窘迫综合征的体外膜肺氧合（ECMO）优先策略。
ASAIO J. 2021 Oct 1;67(10):1097-1099. doi: 10.1097/MAT.0000000000001554.
7
Outcome of acute respiratory distress syndrome requiring extracorporeal membrane oxygenation in Covid-19 or influenza: A single-center registry study.COVID-19 或流感导致急性呼吸窘迫综合征需要体外膜肺氧合治疗的结局：一项单中心登记研究。
Artif Organs. 2021 Jun;45(6):593-601. doi: 10.1111/aor.13865. Epub 2020 Dec 18.
8
Persistent Right Ventricle Dilatation in SARS-CoV-2-Related Acute Respiratory Distress Syndrome on Extracorporeal Membrane Oxygenation Support.COVID-19 相关急性呼吸窘迫综合征患者行体外膜肺氧合支持后持续性右心室扩张。
J Cardiothorac Vasc Anesth. 2022 Jul;36(7):1956-1961. doi: 10.1053/j.jvca.2021.08.028. Epub 2021 Aug 21.
9
Extracorporeal membrane oxygenation (ECMO) in COVID-19 patients: a pocket guide for radiologists.COVID-19 患者体外膜肺氧合（ECMO）：放射科医生袖珍指南。
Radiol Med. 2022 Apr;127(4):369-382. doi: 10.1007/s11547-022-01473-w. Epub 2022 Mar 13.
10
Use of ECMO in Patients With Coronavirus Disease 2019: Does the Evidence Suffice?体外膜肺氧合在2019冠状病毒病患者中的应用：证据是否充分？
J Cardiothorac Vasc Anesth. 2021 Apr;35(4):1256-1262. doi: 10.1053/j.jvca.2020.07.070. Epub 2020 Jul 30.

引用本文的文献

1
Extracorporeal membrane oxygenation for adults with respiratory failure secondary to cardiorespiratory disease: evolving indications and clinical practice.用于患有心肺疾病继发呼吸衰竭的成人的体外膜肺氧合：不断演变的适应症和临床实践
Breathe (Sheff). 2025 Jan 21;21(1):240119. doi: 10.1183/20734735.0119-2024. eCollection 2025 Jan.
2
Multi-horizon predictive models for guiding extracorporeal resource allocation in critically ill COVID-19 patients.多时间尺度预测模型指导 COVID-19 危重症患者体外资源配置。
J Am Med Inform Assoc. 2023 Mar 16;30(4):656-667. doi: 10.1093/jamia/ocac256.
3
Long-term outcomes in patients who received veno-venous extracorporeal membrane oxygenation and renal replacement therapy: a retrospective cohort study.接受静脉-静脉体外膜肺氧合和肾脏替代治疗患者的长期预后：一项回顾性队列研究。
Ann Intensive Care. 2022 Jul 23;12(1):70. doi: 10.1186/s13613-022-01046-0.
4
Where is the imperceptible difference?难以察觉的差异在哪里？
Intensive Care Med. 2022 Jul;48(7):975-976. doi: 10.1007/s00134-022-06710-4. Epub 2022 Apr 26.
5
Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: "perceived futility" and potential underestimation of ECMO's effect.体外膜肺氧合对重症新型冠状病毒肺炎的生存获益：“无用感”及对体外膜肺氧合效果的潜在低估
Intensive Care Med. 2022 Jul;48(7):977-978. doi: 10.1007/s00134-022-06711-3. Epub 2022 Apr 22.

本文引用的文献

1
Where is the imperceptible difference?难以察觉的差异在哪里？
Intensive Care Med. 2022 Jul;48(7):975-976. doi: 10.1007/s00134-022-06710-4. Epub 2022 Apr 26.
2
Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: "perceived futility" and potential underestimation of ECMO's effect.体外膜肺氧合对重症新型冠状病毒肺炎的生存获益：“无用感”及对体外膜肺氧合效果的潜在低估
Intensive Care Med. 2022 Jul;48(7):977-978. doi: 10.1007/s00134-022-06711-3. Epub 2022 Apr 22.
3
Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: a multi-centre-matched cohort study.体外膜肺氧合在重症 COVID-19 中的生存获益：一项多中心匹配队列研究。
Intensive Care Med. 2022 Apr;48(4):467-478. doi: 10.1007/s00134-022-06645-w. Epub 2022 Mar 3.